Jobs
View more job listings or post a job
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Post a job

Workshop

Good Manufacturing Practices (GMPs) from R&D through Commercialization: Fundamentals, Regulatory Trends and Best Practices


Speakers: Marion Weinreb, President, MWA Consulting, Inc.
Organizers:
Date: 2017-10-24
Time: 13:00-17:30 Pacific Time
Registration fee: (USD): Regular: $125; Academic: $75; For unemployed or students: $25; For vendor-show reps: $25; For major-sponsor rep (incl lunch): $0
Location: SF Bay Area: Foster City Crowne Plaza
Major Sponsor: (1)Pacific BioLabs
Vendor show vendors registered to date: (7)BioDuro; BioKey, Inc.; Lonza; MabPlex; MilliporeSigma; Nitto Avecia Pharma Services, Inc.; PerkinElmer
Registration: http://www.PBSS.org
Registration deadline:2017-10-23  (it will close sooner if the seating cap is reached)

About the Topic

This workshop will include a discussion on the history of Good Manufacturing Practices (GMP) regulations from R&D through Commercialization, the importance of the regulations, key definitions, areas covered by the GMPs, a review of the regulations, examples of misconduct and, potential FDA actions.  After completing this workshop, participants should be able to understand the origin, purpose, and expectations of the GMP regulations.

12:45-12:55 pm

  • PBSS Welcome & Workshop Overview  
  • History of Drug Regulations
  • Basis of GMPs  

12:55-2:00 pm

  • CGMPs on a Continuum
    • Development vs Commercial Compliance
    • Review of Clinical Failures and Commercial Recalls     

2:00-2:10 pm

  • Major Sponsor Presentation      

2:10-2:25 pm

  • Break & Vendor Show                          

2:25-3:40 pm

  • Current FDA Expectations and Focus
    • Data Integrity
    • Quality Metrics
    • Quality by Design  

3:40-4:00 pm

  • Break and Vendor Show              

4:00-5:00 pm

  • Oversight of CMOs                                

5:00-5:20pm

  • Q & A

About the Speakers

Marion Weinreb has over 40 years of quality systems experience in the medical device and pharmaceutical industries. Marion has worked at major companies like Altana, Inc., Forest Laboratories, Johnson & Johnson, Syntex and Roche Bioscience. She focuses on GMP and/or QSR auditing in both non-sterile and sterile drug, device and combination systems, Pre-Approval Inspection preparation, PAI mock audits, quality systems development and continuous improvement, cGXP training, GMP document development, and problem resolution for compliance issues. She has worked for small and large companies and has a successful track record for dealing with complex compliance issues in development and commercial settings. Marion holds a BA in Biology and an MS in Pharmaceutical Marketing.  She is currently President of MWA Consulting, Inc. where provides GXP consulting expertise to MWA clients.


2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
©Pharmaceutical & BioScience Society, International; Last Modified: 1/15/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Aliri Bioanalysis to the rescue! Pioneers in LCMS & Oligo bioanalysis w/ 30+ years of experience putting dev. programs back on track with quality data & fast timelines.
Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad